Immunotec Announces Second Quarter 2012 Financial Results
(firmenpresse) - VAUDREUIL-DORION, QUEBEC -- (Marketwire) -- 06/15/12 -- Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company"), today released its 2012 second quarter results for the period ended April 30, 2012.
Second Quarter 2012 Highlights:
(All amounts are in CAD dollars.)
"We are pleased with the result but we are determined to reenergize the Canadian and US segments", said Bob Henry, Immunotec's Chairman and CEO.
Condensed financial results for the second Quarter ended April 30, 2012 are as follows:
ABOUT IMMUNOTEC INC.
Immunotec is a world class business opportunity supported by unique scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Company also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Europe, Mexico and The Caribbean.
The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Company's website at . The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at . Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Patrick Montpetit
VP and Chief Financial Officer
(450) 510-4527
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.06.2012 - 14:05 Uhr
Sprache: Deutsch
News-ID 1124907
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VAUDREUIL-DORION, QUEBEC
Phone:
Kategorie:
Health & Nutrition
Anmerkungen:
Diese Pressemitteilung wurde bisher 244 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Immunotec Announces Second Quarter 2012 Financial Results
"
steht unter der journalistisch-redaktionellen Verantwortung von
Immunotec Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
